AMPK synergizes with the combined treatment of 1'-acetoxychavicol acetate and sodium butyrate to upregulate phase II detoxifying enzyme activities

Yaku, K; Matsui-Yuasa, I; Konishi, Y; Kojima-Yuasa, A

HERO ID

2282970

Reference Type

Journal Article

Year

2013

Language

English

PMID

23559539

HERO ID 2282970
In Press No
Year 2013
Title AMPK synergizes with the combined treatment of 1'-acetoxychavicol acetate and sodium butyrate to upregulate phase II detoxifying enzyme activities
Authors Yaku, K; Matsui-Yuasa, I; Konishi, Y; Kojima-Yuasa, A
Journal Molecular Nutrition and Food Research
Volume 57
Issue 7
Page Numbers 1198-1208
Abstract <strong>SCOPE: </strong>Phase II enzymes play important roles in detoxifying xenobiotics. We previously reported that both 1'-acetoxychavicol acetate (ACA) and sodium butyrate individually increased phase II enzyme activities. Here, we determined the combined action of ACA and sodium butyrate on phase II enzyme activities in intestinal epithelial cells (IEC 6).<br /><br /><strong>METHODS AND RESULTS: </strong>ACA and sodium butyrate synergistically increased phase II enzyme activities. Protein levels of intranuclear transcription factor NF-E2-related factor 2 (Nrf2) were increased by ACA or sodium butyrate treatment, but treatment with both did not produce a synergistic effect. Intranuclear p53 protein levels were increased by ACA but decreased by sodium butyrate alone or combined treatment with ACA and sodium butyrate. In contrast, p53 acetylation was promoted by sodium butyrate and the ACA and sodium butyrate combination. Inhibition of AMPK activity decreased phase II enzyme activities that were upregulated by treatment with ACA plus sodium butyrate or other phytochemicals, including kaempferol, quercetin, and epigallocatechin-3-gallate. Combined treatment with ACA and sodium butyrate increased phosphorylated AMPK levels.<br /><br /><strong>CONCLUSION: </strong>These results suggest that ACA and sodium butyrate synergistically contribute to xenobiotics metabolism. The combined ACA and sodium butyrate treatment synergistically upregulated phase II enzyme activities through AMPK activation and p53 acetylation.
Doi 10.1002/mnfr.201200809
Pmid 23559539
Is Certified Translation No
Dupe Override No
Comments Scopus URL: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879799529&doi=10.1002%2fmnfr.201200809&partnerID=40&md5=10041bd4d7f7899791e4dd50ae2c6df3
Is Public Yes
Language Text English
Keyword 1'-Acetoxychavicol acetate; AMP-activated protein kinase; Dietary fiber; Phase II enzyme; Rat intestine epithelial cells